Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11335639 | 0.91 | MGAM (0.52) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL869610 | 0.86 | DGKA (0.39) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL28722911 | 0.84 | MGAM (0.46) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL16857565 | 0.83 | NAAA (0.41) | ALDH1A1TSHRTDP1HTTL3MBTL1 | |
| SCHEMBL16857561 | 0.83 | NAAA (0.45) | ALDH1A1TSHRHTTL3MBTL1 | |
| SCHEMBL819763 | 0.83 | MGAM (0.44) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL7710928 | 0.81 | ALDH1A1 (0.40) | ALDH1A1TDP1 | |
| SCHEMBL27513497 | 0.81 | — | — | |
| SCHEMBL868662 | 0.81 | — | — | |
| SCHEMBL11338294 | 0.81 | MGAM (0.43) | GAAMGAMSIMGAM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7105194-B2 | Organoleptic compositions: use of 3-mercapto alkanoic acid esters as flavor ingredients | GIVAUDAN SA (CH) | 2006-09-12 | — | — | US | claimed |
| EP-1153547-B1 | Organoleptic compositions | GIVAUDAN SA (CH) | 2004-11-24 | — | — | EP | claimed |
| EP-1153547-A2 | Organoleptic compositions | Givaudan SA (CH) | 2001-11-14 | — | — | EP | claimed |
| US-20010031720-A1 | Organoleptic compositions: use of 3-mercapto alkanoic acid esters as flavor ingredients | GIVAUDAN SA | 2001-10-18 | — | — | US | claimed |
| US-7105194-B2 | Organoleptic compositions: use of 3-mercapto alkanoic acid esters as flavor ingredients | GIVAUDAN SA (CH) | 2006-09-12 | — | — | US | disclosed |
| EP-1153547-B1 | Organoleptic compositions | GIVAUDAN SA (CH) | 2004-11-24 | — | — | EP | disclosed |
| EP-1153547-A2 | Organoleptic compositions | Givaudan SA (CH) | 2001-11-14 | — | — | EP | disclosed |
| US-20010031720-A1 | Organoleptic compositions: use of 3-mercapto alkanoic acid esters as flavor ingredients | GIVAUDAN SA | 2001-10-18 | — | — | US | disclosed |
| US-4320070-A | ION EXCHANGE RESIN CATALYST | PPG INDUSTRIES, INC. (US) | 1982-03-16 | — | — | US | disclosed |
| US-4273725-A | Process for preparing chlorothiolformates | PPG INDUSTRIES, INC. (US) | 1981-06-16 | — | — | US | disclosed |
| US-4268456-A | FROM A MERCAPTAN AND PHOSGENE, QUATERNARY AMMONIUM SALT CATALYST | PPG INDUSTRIES, INC. (US) | 1981-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031720-A1 | Organoleptic compositions: use of 3-mercapto alkanoic acid esters as flavor ingredients | TAS1R1, TAS1R3, TAS2R1 | GAA 3584/4885MGAM 1722/4885SI 969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.